Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients

R. E. A. Tjon Pian Gi, T. Ilmarinen, E. R. van den Heuvel, L. M. Aaltonen, J. Andersen, J. W. Brunings, M. Chirila, A. Dietz, F. Ferran Vila, G. Friedrich, H. H. W. de Gier, W. Golusinski, M. Graupp, A. Hantzakos, R. Horcasitas, J. Jackowska, J. C. Koelmel, G. Lawson, F. Lindner, M. RemacleC. Sittel, V. Weichbold, M. Wierzbicka, F. G. Dikkers

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Scopus)
Original languageEnglish
Pages (from-to)1679-1687
JournalEuropean Archives of Oto-Rhino-Laryngology
Volume270
Issue number5
DOIs
Publication statusPublished - May 2013

Keywords

  • Recurrent respiratory papillomatosis
  • RRP
  • Laryngeal papilloma
  • Cidofovir
  • Side effects
  • Nephrotoxicity
  • Neutropenia
  • Malignancy

Cite this

Gi, R. E. A. T. P., Ilmarinen, T., van den Heuvel, E. R., Aaltonen, L. M., Andersen, J., Brunings, J. W., Chirila, M., Dietz, A., Ferran Vila, F., Friedrich, G., de Gier, H. H. W., Golusinski, W., Graupp, M., Hantzakos, A., Horcasitas, R., Jackowska, J., Koelmel, J. C., Lawson, G., Lindner, F., ... Dikkers, F. G. (2013). Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients. European Archives of Oto-Rhino-Laryngology, 270(5), 1679-1687. https://doi.org/10.1007/s00405-013-2358-7